DMAC
DiaMedica Therapeutics Inc
7.80$
+7.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | -50.4% | +80.9% | -100.0% | – | +0.0% | +14.3% | +4.2% | +20.0% | +30.0% | – | |
| – | – | – | – | – | -104.2% | – | – | – | – | – | – | |
| – | -76.1% | +99.0% | +81.8% | +41.0% | +74.7% | +3.9% | +6.8% | -10.6% | +67.2% | +45.4% | +29.2% | |
| – | -62.2% | +69.6% | +82.9% | +108.6% | +34.8% | +21.7% | +8.6% | +26.2% | +32.4% | -6.5% | +28.3% | |
| – | -72.9% | +89.5% | +72.3% | +69.8% | +59.7% | +9.5% | +7.5% | +2.6% | +51.9% | +25.5% | +28.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +10.1% | -100.0% | – | – | +92.4% | -64.2% | +330.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -70.6% | +79.2% | -140.3% | – | -61.3% | -12.9% | +3.7% | +0.0% | +53.6% | -30.2% | -6.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.